studi
present
data
prospect
studi
adult
patient
communityacquir
pneumonia
cap
patient
includ
studi
age
year
one
underli
diseas
mostli
chronic
obstruct
pulmonari
diseas
diabet
mellitu
dementia
total
microorgan
identifi
patient
two
pathogen
detect
case
microbi
diagnosi
vari
accord
age
sever
comorbid
siteofcar
much
overlap
among
group
streptococcu
pneumonia
singl
preval
organ
outpati
patient
admit
hospit
patient
die
either
singl
pathogen
combin
anoth
organ
infect
caus
atyp
pathogen
seen
across
group
includ
elderli
patient
comorbid
mortal
vari
accord
pneumonia
sever
index
psi
pneumonia
patient
outcom
research
team
shock
age
year
alter
mental
statu
factor
associ
independ
mortal
key
find
studi
advanc
age
popul
cap
high
preval
dementia
underli
diseas
studi
also
reveal
microbiolog
diagnosi
cap
remain
problemat
although
certain
epidemiolog
featur
may
help
predict
microbi
aetiolog
overlap
among
group
reduc
use
inform
guid
therapeut
decis
greater
effort
made
improv
identif
method
microbi
pathogen
caus
cap
complic
increas
concern
regard
concurr
presenc
atyp
pathogen
eg
mycoplasma
pneumonia
chlamydia
spp
coxiella
burnetii
legionella
pneumophila
signific
proport
case
thought
previous
caus
singl
pathogen
mark
rise
blactam
macrolid
resist
among
streptococcu
pneumonia
isol
studi
suggest
current
level
blactam
resist
usual
result
treatment
failur
among
patient
pneumococc
pneumonia
therapeut
failur
attribut
macrolideresist
pneumonia
report
among
patient
treat
oral
macrolid
requir
admiss
subsequ
pneumonia
bacteraemia
howev
avail
newer
fluoroquinolon
greater
activ
pneumonia
respiratori
pathogen
well
novel
immunochromatograph
assay
detect
pneumonia
l
pneumophila
antigen
urin
facilit
medic
manag
cap
largescal
studi
epidemiolog
cap
labourintens
abovement
chang
controversi
mean
new
epidemiolog
data
requir
previou
studi
cap
focus
either
patient
admit
hospit
outpati
aim
present
work
provid
comprehens
overview
current
clinic
epidemiolog
featur
cap
conduct
prospect
populationbas
studi
two
major
advantag
inclus
consecut
patient
cover
broad
clinic
spectrum
cap
extens
microbiolog
workup
includ
detect
urinari
antigen
pneumonia
l
pneumophila
standard
serolog
test
criteria
atyp
viru
pathogen
previou
report
evalu
binax
immunochromatograph
assay
detect
pneumonia
urinari
antigen
patient
cohort
present
studi
present
complet
analysi
epidemiolog
featur
microbi
diagnosi
outcom
patient
prospect
observ
cohort
studi
conduct
octob
octob
hospit
gener
universitario
de
elch
universityaffili
teach
hospit
serv
popul
three
municip
health
author
bajo
mediterranean
coast
spain
adult
patient
year
health
author
sign
symptom
compat
pneumonia
studi
period
elig
inclus
studi
studi
approv
local
ethic
committe
attend
clinician
ask
consid
possibl
pneumonia
patient
acut
ill
symptom
suggest
lower
respiratori
tract
infect
includ
new
cough
high
fever
chill
pleurit
chest
pain
dyspnoea
prolong
fever
patient
evalu
clinic
roentgenograph
provision
diagnosi
cap
seen
studi
investig
confirm
diagnosi
cap
defin
acut
ill
associ
least
one
follow
sign
symptom
fever
new
cough
without
sputum
product
pleurit
chest
pain
dyspnoea
alter
breath
sound
auscult
plu
chest
radiograph
show
opac
compat
presenc
acut
pneumonia
patient
hospitalis
previous
within
week
current
diagnosi
pneumonia
exclud
demograph
clinic
data
collect
studi
investig
use
written
standardis
questionnair
pneumonia
sever
index
psi
pneumonia
patient
outcom
research
team
port
classifi
patient
five
risk
class
accord
outcom
stage
includ
patient
favour
prognosi
stage
v
includ
poorest
prognosi
use
calcul
sever
pneumonia
present
repeat
chest
radiogram
blood
sampl
obtain
week
initi
diagnosi
cap
patient
follow
least
week
death
mortal
defin
death
caus
within
day
diagnosi
pneumonia
laboratori
investig
patient
cap
includ
sputum
sampl
gram
stain
cultur
patient
product
cough
two
blood
sampl
cultur
patient
fever
urin
sampl
detect
pneumonia
l
pneumophila
urinari
antigen
patient
except
urin
sampl
could
collect
start
antibiot
therapi
serum
sampl
serolog
test
drawn
acut
convalesc
phase
ill
patient
except
die
convalesc
sampl
due
obtain
fail
attend
followup
visit
bronchoscop
sampl
obtain
also
cultur
qualifi
sputum
sampl
white
blood
cell
squamou
cell
lowmagnif
field
evalu
hospit
staff
charg
patient
ask
collect
sputum
sampl
start
antibiot
therapi
binax
immunochromatograph
assay
binax
portland
usa
use
detect
pneumonia
antigen
l
pneumophila
serogroup
antigen
urin
sampl
collect
time
diagnosi
cap
complement
fixat
cf
test
perform
detect
antibodi
pneumonia
chlamydia
spp
cox
burnetii
influenza
virus
b
respiratori
syncyti
viru
adenoviru
cf
test
follow
standard
micromethod
heatinactiv
sera
titrat
dilut
four
unit
commerci
avail
antigen
institut
virion
schlikon
zurich
switzerland
u
guineapig
complement
use
cf
test
antibodi
titr
read
highest
dilut
show
haemolysi
indirect
immunofluoresc
test
use
detect
antibodi
l
pneumophila
vircel
granada
spain
microimmunofluoresc
test
use
detect
antibodi
c
pneumonia
chlamydia
psittaci
chlamydia
trachomati
vircel
granada
spain
follow
criteria
use
classifi
pneumonia
known
aetiolog
fourfold
greater
rise
antibodi
titr
cf
test
pneumonia
c
psittaci
cox
burnetii
influenza
virus
b
respiratori
syncyti
viru
adenoviru
fourfold
rise
antibodi
titr
presenc
igm
antibodi
c
pneumonia
isol
respiratori
sampl
detect
antigen
urin
fourfold
greater
rise
immunofluoresc
antibodi
titr
l
pneumophila
isol
blood
pleural
fluid
predomin
organ
isol
qualifi
sputum
sampl
antigen
pneumonia
detect
urin
isol
blood
pleural
fluid
predomin
organ
isol
qualifi
sputum
sampl
haemophilu
influenza
moraxella
catarrhali
staphylococcu
aureu
bacteria
includ
gramneg
enterobacteria
case
fulfil
diagnost
criteria
consid
pneumonia
unknown
aetiolog
case
fulfil
diagnost
criteria
one
pathogen
consid
repres
mix
pneumonia
case
fourfold
antibodi
rise
one
speci
chlamydia
exclud
definit
mix
pneumonia
possibl
nonspecif
crossreact
descript
statist
comput
standard
method
differ
specifi
group
detect
chisquar
test
fisher
exact
test
appropri
categor
variabl
mannwhitney
utest
student
ttest
continu
variabl
multivari
analysi
factor
potenti
associ
mortal
perform
stepwis
logist
regress
includ
signific
variabl
univari
analysi
clinic
import
variabl
whether
signific
twotail
p
valu
consid
signific
associ
independ
variabl
outcom
assess
odd
ratio
confid
interv
ci
statist
analys
perform
spss
v
softwar
spss
inc
chicago
il
usa
patient
sign
symptom
compat
pneumonia
found
subsequ
cap
lower
respiratori
tract
infect
without
pneumonia
heart
failur
pulmonari
embol
lung
cancer
bronchiectasi
atelectasi
pulmonari
fibrosi
pulmonari
haemorrhag
leav
patient
studi
cohort
main
demograph
characterist
patient
summaris
tabl
total
patient
admit
hospit
mean
sd
stay
day
remain
patient
manag
outpati
mean
sd
psi
score
patient
admit
hospit
compar
outpati
p
ambulatori
patient
classifi
within
risk
class
ii
psi
distribut
patient
admit
hospit
accord
psi
risk
class
follow
ii
iii
iv
v
patient
characterist
vari
accord
age
comorbid
ill
common
patient
age
year
younger
patient
vs
p
predispos
factor
aspir
pneumonia
reduc
level
conscious
underli
neurolog
diseas
dysphagia
impair
gag
reflex
sever
periodont
diseas
also
significantli
frequent
patient
age
year
younger
patient
vs
p
distribut
caus
microorgan
age
group
shown
also
common
older
patient
case
diagnos
patient
age
year
atyp
pathogen
preval
younger
patient
show
declin
trend
age
signific
trend
accord
age
group
incid
pneumonia
caus
pathogen
comorbid
also
relat
aetiolog
cap
tabl
overal
infect
caus
atyp
pathogen
seen
frequent
patient
without
comorbid
wherea
bacteri
infect
tend
occur
commonli
patient
underli
condit
pneumonia
singl
preval
organ
group
detect
frequent
patient
underli
diseas
vs
p
pneumonia
caus
gramneg
enter
bacilli
pseudomona
spp
also
common
among
patient
comorbid
condit
account
case
compar
patient
without
comorbid
condit
p
overal
episod
bacteri
infect
occur
patient
comorbid
compar
patient
without
underli
diseas
p
contrast
bacteri
infect
episod
atyp
infect
occur
patient
without
underli
diseas
compar
patient
comorbid
p
patient
without
comorbid
atyp
organ
frequent
group
pathogen
account
pneumonia
case
interestingli
wherea
pneumonia
caus
mycoplasma
chlamydia
spp
common
among
patient
without
comorbid
preval
chlamydia
pneumonia
case
chlamydia
psittaci
nine
case
six
case
fourfold
rise
antibodi
c
psittaci
c
pneumonia
l
pneumophila
patient
without
comorbid
overal
frequenc
viru
infect
also
similar
patient
without
underli
diseas
pneumonia
caus
respiratori
syncyti
viru
seen
patient
comorbid
aetiolog
distribut
found
patient
three
major
underli
diseas
shown
tabl
particular
note
lead
posit
pneumonia
group
signific
associ
pseudomona
spp
chronic
obstruct
pulmonari
diseas
microbi
diagnosi
cap
also
vari
accord
sever
siteofcar
pneumonia
singl
preval
organ
specifi
group
patient
classifi
lowsever
risk
class
iiii
psi
pneumonia
pneumonia
c
pneumonia
pathogen
detect
frequent
tabl
compar
patient
highsever
risk
class
classifi
lowsever
class
higher
preval
atyp
pathogen
class
iiii
vs
class
iv
v
p
main
aetiolog
agent
identifi
highsever
risk
class
iv
v
pneumonia
l
pneumophila
pneumonia
chlamydia
spp
rare
among
patient
highsever
risk
class
tabl
distribut
aetiolog
agent
siteofcar
mimick
distribut
accord
sever
tabl
pneumonia
organ
detect
frequent
inpati
outpati
signific
differ
inpati
outpati
preval
infect
caus
atyp
pathogen
occur
frequent
outpati
patient
admit
hospit
vs
p
fifteen
case
pneumonia
caus
gramneg
bacilli
pseudomona
spp
diagnos
patient
admit
hospit
analysi
differ
variabl
show
lower
rate
hospit
admiss
patient
atyp
aetiolog
compar
bacteri
p
unknown
p
aetiolog
hospitalis
rate
highest
patient
infect
gramneg
bacilli
includ
pseudomona
spp
follow
infect
one
organ
pneumococci
unidentifi
organ
virus
pneumonia
exclud
patient
die
mean
rang
hospit
stay
day
mean
period
hospitalis
longer
patient
bacteri
pneumonia
day
atyp
pathogen
day
p
viral
pneumonia
day
p
chlamydia
pneumonia
case
chlamydia
psittaci
nine
case
six
case
fourfold
rise
antibodi
c
psittaci
c
pneumonia
patient
treatment
inform
avail
receiv
combin
therapi
macrolid
plu
blactam
antibiot
receiv
monotherapi
blactam
receiv
macrolid
alon
receiv
respiratori
fluoroquinolon
receiv
antibiot
antibiot
prescrib
vari
accord
siteofcar
monotherapi
macrolid
prescrib
predominantli
outpati
set
prescript
wherea
combin
therapi
given
mostli
patient
admit
hospit
prescript
fortythre
cours
fluoroquinolon
administ
outpati
hospitalis
patient
patient
admit
hospit
die
within
followup
period
mortal
rate
ci
caus
pathogen
identifi
patient
die
pneumonia
n
pseudomona
spp
n
escherichia
coli
n
mix
infect
pneumonia
pseudomona
spp
two
case
pneumonia
staph
aureu
one
case
five
ambulatori
patient
eventu
requir
hospit
admiss
five
favour
outcom
overal
mortal
rate
includ
inpati
outpati
ci
mortal
accord
psi
risk
class
follow
class
ii
two
case
class
iii
two
case
class
iv
case
class
v
nine
case
addit
psi
risk
class
follow
variabl
associ
significantli
mortal
univari
analysi
age
year
presenc
comorbid
shock
alter
mental
statu
admiss
increas
respiratori
rate
min
respiratori
failur
po
f
renal
failur
creatinin
mmol
l
bacteraemia
aspir
pneumonia
antibiot
therapi
includ
macrolid
fluoroquinolon
tabl
associ
found
gender
previou
antibiot
therapi
immunodepress
temperatur
present
white
blood
cell
count
multilobar
involv
gramneg
pneumonia
infect
pseudomona
spp
mortal
multivari
analysi
shock
age
year
alter
mental
statu
independ
predictor
mortal
statist
signific
potenti
associ
antimicrobi
regimen
either
complic
mortal
explor
univari
multivari
analysi
differ
subgroup
patient
associ
combin
antimicrobi
therapi
either
complic
mortal
patient
particular
aetiolog
cap
includ
bacteri
pneumonia
mix
pneumonia
pneumococc
pneumonia
gramneg
pneumonia
although
associ
found
combin
antimicrobi
therapi
includ
either
macrolid
fluoroquinolon
reduc
mortal
univari
analysi
associ
confirm
multivari
analysi
prospect
studi
provid
comprehens
data
larg
cohort
patient
cap
offer
updat
epidemiolog
inform
may
especi
relev
light
recent
develop
mani
aspect
diseas
uniform
sampl
group
patient
comprehens
search
microorgan
use
standard
diagnost
test
criteria
establish
aetiolog
diagnosi
form
import
addit
present
knowledg
epidemiolog
cap
among
interest
observ
cohort
older
age
popul
compar
previou
populationbas
studi
high
preval
dementia
underli
diseas
older
age
popul
may
account
part
higher
proport
patient
admit
hospit
compar
populationbas
studi
carri
last
decad
present
studi
dementia
emerg
signific
comorbid
ill
patient
cap
rank
chronic
obstruct
pulmonari
diseas
diabet
mellitu
pneumonia
one
seriou
medic
condit
seen
latestag
dementia
common
caus
death
patient
high
preval
dementia
observ
present
studi
probabl
relat
popul
age
also
reflect
older
age
patient
includ
studi
although
alzheim
diseas
increas
problem
elderli
affect
million
individu
usa
alon
presenc
dementia
found
major
risk
factor
cap
epidemiolog
studi
publish
last
decad
howev
recent
studi
cap
patient
age
year
admit
hospit
found
dementia
fourth
common
underli
diseas
chronic
obstruct
pulmonari
diseas
chronic
heart
diseas
diabet
mellitu
patient
dementia
may
particularli
suscept
pneumonia
swallow
difficulti
use
sed
medic
factor
found
increas
risk
pneumonia
elderli
patient
live
longterm
care
facil
problem
pneumonia
patient
dementia
may
seriou
futur
view
forecast
continu
increas
number
individu
alzheim
diseas
disappoint
find
studi
fact
despit
introduct
urinari
antigen
test
pneumonia
l
pneumophila
extens
serolog
test
perform
aetiolog
remain
unidentifi
half
case
confirm
microbi
diagnosi
cap
remain
problemat
howev
neither
nonserolog
test
virus
eg
immunofluoresc
viru
cultur
nucleic
acid
amplif
techniqu
use
attempt
made
look
emerg
virus
coronaviru
human
metapneumoviru
hantaviru
result
obtain
show
high
proport
patient
pneumococc
cap
pneumonia
frequent
organ
identifi
outpati
patient
requir
admiss
hospit
also
frequent
pathogen
involv
mix
infect
fatal
case
find
concur
result
previou
studi
one
follow
condit
diabet
chronic
lung
heart
diseas
chronic
liver
diseas
chronic
renal
insuffici
cancer
immunosuppress
dementia
malnutrit
hospitalis
patient
frequenc
pneumonia
outpati
vari
wide
studi
identifi
atyp
organ
pneumonia
c
pneumonia
virus
frequent
pneumonia
differ
probabl
reflect
differ
popul
studi
type
diagnost
test
perform
result
present
studi
support
high
preval
cap
caus
atyp
pathogen
report
previous
reach
diagnos
case
present
cohort
pneumonia
account
atyp
pathogen
observ
agre
result
studi
pneumonia
account
atyp
pathogen
reinforc
pivot
role
organ
cap
contrast
import
c
pneumonia
yet
complet
understood
last
year
c
pneumonia
identifi
increas
frequenc
studi
reach
proport
compar
ever
higher
mycoplasma
found
rare
cohort
lack
refer
standard
diagnosi
combin
occurr
epidem
outbreak
studi
may
account
part
wide
variat
report
incid
rate
order
determin
signific
c
pneumonia
caus
pneumonia
popul
critic
use
standard
diagnost
test
criteria
perform
studi
suffici
length
time
avoid
season
bia
present
studi
use
cdc
criteria
diagnos
definit
acut
infect
serolog
patient
recruit
period
accord
result
c
pneumonia
signific
pathogen
cap
frequenc
lower
pneumonia
much
lower
found
pneumonia
studi
comparison
aetiolog
age
group
comorbid
mani
similar
also
differ
overal
preval
cap
caus
atyp
organ
highest
among
young
adult
patient
without
comorbid
reflect
epidemiolog
pattern
mycoplasma
chlamydia
infect
contrast
pneumonia
caus
legionella
seen
similar
frequenc
young
older
individu
patient
without
comorbid
although
mycoplasma
chlamydia
infect
common
youngest
patient
case
pneumonia
caus
organ
occur
patient
age
year
find
agre
studi
report
signific
incid
rate
cap
caus
atyp
pathogen
elderli
patient
comorbid
regard
aetiolog
distribut
accord
underli
diseas
pneumonia
held
lead
posit
group
signific
associ
pseudomona
spp
chronic
obstruct
pulmonari
diseas
case
staphylococc
pneumonia
among
diabet
patient
observ
analysi
aetiolog
siteofcar
sever
pneumonia
singl
preval
organ
patient
admit
hospit
outpati
lowand
highsever
risk
class
emphasis
empir
antibiot
therapi
alway
activ
pneumococci
incid
cap
caus
atyp
pathogen
includ
pneumonia
c
pneumonia
highest
among
outpati
also
high
among
hospitalis
patient
import
pneumonia
c
pneumonia
legionella
pneumonia
requir
hospitalis
highlight
sever
previou
studi
cap
although
atyp
pathogen
legionella
spp
usual
associ
mildtomoder
ill
sever
case
requir
admiss
intens
care
unit
also
report
cbpi
studi
pneumonia
caus
pneumonia
c
pneumonia
account
use
criteria
definit
diagnosi
use
criteria
possibl
diagnosi
patient
pneumonia
requir
hospitalis
recent
studi
found
cap
patient
age
year
chlamydia
infect
highest
hospitalis
rate
lead
suggest
pneumonia
caus
chlamydia
rival
even
pneumococc
pneumonia
sever
howev
littl
inform
actual
avail
sever
present
atyp
pneumonia
use
valid
prognost
tool
result
present
studi
use
valid
port
predict
rule
mortal
medic
complic
quantifi
sever
ill
present
suggest
sever
cap
caus
atyp
organ
may
overestim
inde
patient
cap
caus
pneumonia
c
pneumonia
diseas
low
sever
patient
favour
outcom
accord
current
recommend
case
probabl
treat
home
legionella
spp
long
consid
common
pathogen
caus
sever
cap
howev
frequenc
legionella
spp
identifi
case
seri
sever
cap
rang
organ
found
rare
larg
french
studi
recent
populationbas
data
show
case
legionella
infect
probabl
present
mildtomoder
diseas
rather
sever
pneumonia
largest
outbreak
legionnair
diseas
date
case
report
onethird
patient
manag
outpati
case
fatal
rate
observ
present
populationbas
studi
use
port
classif
case
legionnair
diseas
classifi
within
lowsever
six
within
highsever
risk
class
four
case
manag
outpati
one
patient
admit
requir
treatment
intens
care
unit
none
patient
die
import
epidemiolog
data
guid
empir
therapeut
decis
patient
cap
recognis
differ
guidelin
specialist
scientif
societi
thu
patient
cap
often
classifi
group
list
like
pathogen
suggest
empir
therapi
base
stratif
accord
age
place
therapi
comorbid
sever
present
data
confirm
microbi
diagnosi
vari
accord
epidemiolog
factor
much
overlap
group
inform
use
guid
therapeut
decis
select
empir
therapi
complic
mark
increas
blactam
macrolid
resist
among
isol
pneumonia
increas
concern
mix
infect
low
proport
case
cap
present
studi
consid
mix
aetiolog
mix
infect
seen
across
age
group
includ
elderli
patient
hospitalis
patient
outpati
although
import
treat
multipl
infect
pathogen
establish
sever
observ
studi
indic
use
macrolid
cephalosporin
part
initi
empir
regimen
patient
cap
admit
hospit
may
associ
shorter
length
hospit
stay
lower
mortal
rate
treatment
cephalosporin
alon
addit
recent
data
suggest
advantag
use
empir
blactammacrolid
combin
rather
monotherapi
treatment
cap
associ
subsequ
pneumococc
bacteraemia
howev
investig
retrospect
design
limit
sever
sourc
bia
present
studi
combin
therapi
associ
better
outcom
multivari
analysi
compar
monotherapi
although
frequent
involv
pneumococci
mix
pneumonia
would
support
role
dual
therapi
pneumococ
infect
associ
demonstr
combin
antibiot
therapi
outcom
patient
pneumococc
pneumonia
although
find
may
argu
use
dual
therapi
patient
pneumococc
pneumonia
result
interpret
caution
rel
small
size
group
affect
power
gener
applic
find
addit
state
updat
guidelin
cap
infecti
diseas
societi
america
time
prospect
randomis
trial
clarifi
issu
identif
pneumococci
prevent
clinician
pursu
diagnost
possibl
eg
atyp
copathogen
especi
pneumonia
respond
treatment
overal
mortal
rate
present
studi
figur
similar
found
recent
communitybas
studi
cap
patient
requir
hospitalis
mortal
rate
resembl
rate
cbpi
studi
lower
figur
report
previous
averag
age
diseas
sever
underli
diseas
reflect
psi
predict
rule
factor
affect
outcom
inde
mortal
vari
accord
psi
fatal
case
occur
patient
classifi
within
risk
class
iv
v
although
sever
variabl
associ
mortal
univari
analysi
shock
age
year
alter
mental
statu
associ
independ
increas
mortal
state
associ
found
multivari
analysi
mortal
either
monotherapi
combin
antibiot
therapi
summari
studi
cap
conduct
begin
centuri
confirm
mani
epidemiolog
featur
known
previou
studi
also
disclos
interest
novel
aspect
diseas
studi
confirm
microbi
diagnosi
cap
remain
problemat
aetiolog
still
identifi
consider
proport
case
although
certain
epidemiolog
featur
may
help
predict
microbi
aetiolog
overlap
group
reduc
use
inform
guid
therapeut
decis
new
microbiolog
techniqu
requir
improv
abil
laboratori
detect
microbi
pathogen
caus
cap
